|
MAP4K3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70752301187349E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.59712259978551E-14 |
| Normal-vs-Stage2 |
8.15389999964111E-07 |
| Normal-vs-Stage3 |
1.13080000918586E-09 |
| Normal-vs-Stage4 |
6.863900E-03 |
| Stage1-vs-Stage2 |
4.225200E-01 |
| Stage1-vs-Stage3 |
4.164200E-01 |
| Stage1-vs-Stage4 |
5.688600E-01 |
| Stage2-vs-Stage3 |
7.315200E-01 |
| Stage2-vs-Stage4 |
9.875200E-01 |
| Stage3-vs-Stage4 |
8.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55431223447522E-14 |
| Normal-vs-AfricanAmerican |
3.03290004222134E-09 |
| Normal-vs-Asian |
2.755900E-03 |
| Caucasian-vs-AfricanAmerican |
3.018400E-01 |
| Caucasian-vs-Asian |
3.398600E-01 |
| AfricanAmerican-vs-Asian |
5.978200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33226762955019E-15 |
| Normal-vs-Female |
1.54725999998995E-05 |
| Male-vs-Female |
9.80329999999974E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.98249999999423E-05 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.83080217652787E-11 |
| Normal-vs-Extreme_Obese |
4.50110000049797E-07 |
| Normal_Weight-vs-Extreme_Weight |
4.888000E-02 |
| Normal_Weight-vs-Obese |
4.862200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.893000E-01 |
| Extreme_Weight-vs-Obese |
2.838100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.162600E-01 |
| Obese-vs-Extreme_Obese |
7.359200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.641000E-03 |
| Normal-vs-Age(41-60Yrs) |
6.76902978113958E-13 |
| Normal-vs-Age(61-80Yrs) |
9.65894031423886E-15 |
| Normal-vs-Age(81-100Yrs) |
3.10609982179244E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.847600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.797600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.001880E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.853160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.488570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.21739999589832E-08 |
| Normal-VS-KIRP CIMP |
5.199200E-01 |
| Normal-VS-Unclassified PRCC |
2.00319999477117E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.347800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.044360E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.022980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.291800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.847600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.037200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.185770E-04 |
| Normal-vs-N2 |
3.821600E-01 |
| N0-vs-N1 |
2.402400E-02 |
| N0-vs-N2 |
3.315000E-01 |
| N1-vs-N2 |
6.135600E-01 |
|
|
